{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:44:22Z","timestamp":1789713862519,"version":"4.0.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.apsb.2024.06.021","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T19:25:09Z","timestamp":1719602709000},"page":"5357-5369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Discovery of highly potent phosphodiesterase-1 inhibitors by a combined-structure free energy perturbation approach"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9357-6839","authenticated-orcid":false,"given":"Zhe","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runduo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-You","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinuo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Guo","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2163-0509","authenticated-orcid":false,"given":"Hai-Bin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2024.06.021_bib1","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nrd1549","article-title":"Docking and scoring in virtual screening for drug discovery: methods and applications","volume":"3","author":"Kitchen","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2024.06.021_bib2","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1021\/jm049081q","article-title":"Validation and use of the MM-PBSA approach for drug discovery","volume":"48","author":"Kuhn","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2024.06.021_bib3","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","article-title":"End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design","volume":"119","author":"Wang","year":"2019","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2024.06.021_bib4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/protein\/7.3.385","article-title":"A new method for predicting binding affinity in computer-aided drug design","volume":"7","author":"\u00c5qvist","year":"1994","journal-title":"Protein Eng Des Sel"},{"key":"10.1016\/j.apsb.2024.06.021_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/A:1007930623000","article-title":"Ligand binding affinity prediction by linear interaction energy methods","volume":"12","author":"Hansson","year":"1998","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.apsb.2024.06.021_bib6","first-page":"1420","article-title":"High-temperature equation of state by a perturbation method. I. Nonpolar gases","volume":"22","author":"Zwanzig","year":"1954","journal-title":"J Comput Phys"},{"key":"10.1016\/j.apsb.2024.06.021_bib7","first-page":"1915","article-title":"High-temperature equation of state by a perturbation method. II. Polar gases","volume":"23","author":"Zwanzig","year":"1955","journal-title":"J Comput Phys"},{"key":"10.1016\/j.apsb.2024.06.021_bib8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1039\/C5SC02678D","article-title":"Accurate calculation of the absolute free energy of binding for drug molecules","volume":"7","author":"Aldeghi","year":"2016","journal-title":"Chem Sci"},{"key":"10.1016\/j.apsb.2024.06.021_bib9","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1021\/jacs.6b11467","article-title":"Predictions of ligand selectivity from absolute binding free energy calculations","volume":"139","author":"Aldeghi","year":"2017","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.apsb.2024.06.021_bib10","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1021\/acs.jcim.1c00269","article-title":"BFEE2: automated, streamlined, and accurate absolute binding free-energy calculations","volume":"61","author":"Fu","year":"2021","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.apsb.2024.06.021_bib11","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/s41596-021-00676-1","article-title":"Accurate determination of protein:ligand standard binding free energies from molecular dynamics simulations","volume":"17","author":"Fu","year":"2022","journal-title":"Nat Protoc"},{"key":"10.1016\/j.apsb.2024.06.021_bib12","doi-asserted-by":"crossref","first-page":"27381","DOI":"10.1073\/pnas.2010470117","article-title":"Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs","volume":"117","author":"Li","year":"2020","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.apsb.2024.06.021_bib13","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1021\/acs.jmedchem.8b01763","article-title":"Absolute binding free energy calculation and design of a subnanomolar inhibitor of phosphodiesterase-10","volume":"62","author":"Li","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2024.06.021_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/10943420221117797","article-title":"Free energy perturbation-based large-scale virtual screening for effective drug discovery against COVID-19","volume":"37","author":"Li","year":"2022","journal-title":"Int J High Perform Comput Appl"},{"key":"10.1016\/j.apsb.2024.06.021_bib15","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.apsb.2021.09.027","article-title":"Free energy perturbation (FEP)-guided scaffold hopping","volume":"12","author":"Wu","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.06.021_bib16","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.apsb.2020.04.008","article-title":"Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19","volume":"10","author":"Liu","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.06.021_bib17","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2024420118","article-title":"Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors","volume":"118","author":"Ma","year":"2021","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.apsb.2024.06.021_bib18","article-title":"Reply to Ma and Wang: reliability of various in\u00a0vitro activity assays on SARS-CoV-2 main protease inhibitors","volume":"118","author":"Li","year":"2021","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.apsb.2024.06.021_bib19","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2106095118","article-title":"Inhibitor potency and assay conditions: a case study on SARS-CoV-2 main protease","volume":"118","author":"Behnam","year":"2021","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.apsb.2024.06.021_bib20","article-title":"Reply to behnam and klein:\u00a0potential role of the his-tag in C-terminal his-tagged SARS-CoV-2 main protease","volume":"118","author":"Li","year":"2021","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.apsb.2024.06.021_bib21","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s43588-021-00180-2","volume":"1","year":"2021","journal-title":"Nat Comput Sci"},{"key":"10.1016\/j.apsb.2024.06.021_bib22","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1021\/ja512751q","article-title":"Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force field","volume":"137","author":"Wang","year":"2015","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.apsb.2024.06.021_bib23","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1021\/acs.jcim.9b00105","article-title":"Using AMBER18 for relative free energy calculations","volume":"59","author":"Song","year":"2019","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.apsb.2024.06.021_bib24","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1021\/ja00273a048","article-title":"Dynamics and design of enzymes and inhibitors","volume":"108","author":"Wong","year":"1986","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.apsb.2024.06.021_bib25","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1021\/acs.jcim.0c00613","article-title":"Alchemical binding free energy calculations in AMBER20: advances and best practices for drug discovery","volume":"60","author":"Lee","year":"2020","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.apsb.2024.06.021_bib26","doi-asserted-by":"crossref","first-page":"9025","DOI":"10.1063\/1.466707","article-title":"Separation-shifted scaling, a new scaling method for Lennard-Jones interactions in thermodynamic integration","volume":"100","author":"Zacharias","year":"1994","journal-title":"J Chem Phys"},{"key":"10.1016\/j.apsb.2024.06.021_bib27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0009-2614(94)00397-1","article-title":"Avoiding singularities and numerical instabilities in free energy calculations based on molecular simulations","volume":"222","author":"Beutler","year":"1994","journal-title":"Chem Phys Lett"},{"key":"10.1016\/j.apsb.2024.06.021_bib28","doi-asserted-by":"crossref","DOI":"10.1063\/1.5123154","article-title":"Perturbation potentials to overcome order\/disorder transitions in alchemical binding free energy calculations","volume":"151","author":"Pal","year":"2019","journal-title":"J Chem Phys"},{"key":"10.1016\/j.apsb.2024.06.021_bib29","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1021\/acs.jcim.9b00362","article-title":"Computing relative binding affinity of ligands to receptor: an effective hybrid single-dual-topology free-energy perturbation approach in NAMD","volume":"59","author":"Jiang","year":"2019","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.apsb.2024.06.021_bib30","doi-asserted-by":"crossref","DOI":"10.1063\/1.4826261","article-title":"Calculating the binding free energies of charged species based on explicit-solvent simulations employing lattice-sum methods: an accurate correction scheme for electrostatic finite-size effects","volume":"139","author":"Rocklin","year":"2013","journal-title":"J Chem Phys"},{"key":"10.1016\/j.apsb.2024.06.021_bib31","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1021\/acs.jcim.1c01532","article-title":"Modified Hamiltonian in FEP calculations for reducing the computational cost of electrostatic interactions","volume":"62","author":"Oshima","year":"2022","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.apsb.2024.06.021_bib32","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1021\/acs.jctc.2c00697","article-title":"ACES: optimized alchemically enhanced sampling","volume":"19","author":"Lee","year":"2023","journal-title":"J Chem Theor Comput"},{"key":"10.1016\/j.apsb.2024.06.021_bib33","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1021\/acs.jctc.0c00237","article-title":"Improved alchemical free energy calculations with optimized smoothstep softcore potentials","volume":"16","author":"Lee","year":"2020","journal-title":"J Chem Theor Comput"},{"key":"10.1016\/j.apsb.2024.06.021_bib34","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1021\/acs.jctc.2c00725","article-title":"AMBER free energy tools: a new framework for the design of optimized alchemical transformation pathways","volume":"19","author":"Tsai","year":"2023","journal-title":"J Chem Theor Comput"},{"key":"10.1016\/j.apsb.2024.06.021_bib35","doi-asserted-by":"crossref","first-page":"7867","DOI":"10.1021\/acs.jmedchem.0c00711","article-title":"Discovery of novel selective and orally bioavailable phosphodiesterase-1 inhibitors for the efficient treatment of idiopathic pulmonary fibrosis","volume":"63","author":"Wu","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2024.06.021_bib36","doi-asserted-by":"crossref","first-page":"8444","DOI":"10.1021\/acs.jmedchem.2c00458","article-title":"Structural modifications of nimodipine lead to novel PDE1 inhibitors with anti-pulmonary fibrosis effects","volume":"65","author":"Huang","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2024.06.021_bib37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J Mol Graph"},{"key":"10.1016\/j.apsb.2024.06.021_bib38","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jcc.22885","article-title":"Multiwfn: a multifunctional wavefunction analyzer","volume":"33","author":"Lu","year":"2011","journal-title":"J Comput Chem"},{"key":"10.1016\/j.apsb.2024.06.021_bib39","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1021\/acs.jctc.8b00544","article-title":"Reproducibility of free energy calculations across different molecular simulation software packages","volume":"14","author":"Loeffler","year":"2018","journal-title":"J Chem Theor Comput"},{"key":"10.1016\/j.apsb.2024.06.021_bib40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0021-9991(76)90078-4","article-title":"Efficient estimation of free energy differences from Monte Carlo data","volume":"22","author":"Bennett","year":"1976","journal-title":"J Comput Phys"},{"key":"10.1016\/j.apsb.2024.06.021_bib41","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1021\/acs.jcim.2c01076","article-title":"An open source graph-based weighted cycle closure method for relative binding free energy calculations","volume":"63","author":"Li","year":"2023","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.apsb.2024.06.021_bib42","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.33011\/livecoms.4.1.1497","article-title":"Best practices for constructing, preparing, and evaluating protein\u2012ligand binding affinity benchmarks [Article v1.0]","volume":"4","author":"Hahn","year":"2022","journal-title":"Living J Comp Mol Sci"},{"key":"10.1016\/j.apsb.2024.06.021_bib43","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1164\/rccm.202007-2794OC","article-title":"Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. an international multicenter study","volume":"202","author":"Drake","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.apsb.2024.06.021_bib44","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S2213-2600(20)30225-3","article-title":"Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy","volume":"8","author":"George","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.apsb.2024.06.021_bib45","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.3390\/jcm9061917","article-title":"COVID-19: the potential treatment of pulmonary fibrosis associated with SARS-CoV-2 infection","volume":"9","author":"Lechowicz","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.apsb.2024.06.021_bib46","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1016\/j.cell.2021.11.033","article-title":"SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis","volume":"184","author":"Wendisch","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2024.06.021_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109418","article-title":"Lung fibrosis: post-COVID-19 complications and evidences","volume":"116","author":"Hirawat","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.apsb.2024.06.021_bib48","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1021\/ci400063s","article-title":"Identification of novel phosphodiesterase-4D inhibitors prescreened by molecular dynamics-augmented modeling and validated by bioassay","volume":"53","author":"Li","year":"2013","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.apsb.2024.06.021_bib49","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1021\/acs.jmedchem.9b00224","article-title":"Validation of phosphodiesterase-10 as a novel target for pulmonary arterial hypertension via highly selective and subnanomolar Inhibitors","volume":"62","author":"Huang","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2024.06.021_bib50","doi-asserted-by":"crossref","first-page":"13736","DOI":"10.1021\/acs.jmedchem.1c01085","article-title":"Mangostanin derivatives as novel and orally active phosphodiesterase 4 inhibitors for the treatment of idiopathic pulmonary\u00a0fibrosis\u00a0with improved safety","volume":"64","author":"Huang","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2024.06.021_bib51","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1021\/acs.jmedchem.1c02058","article-title":"Discovery and structural optimization of toddacoumalone derivatives as novel PDE4 inhibitors for the topical treatment of psoriasis","volume":"65","author":"Song","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2024.06.021_bib52","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1016\/j.apsb.2022.02.012","article-title":"Structure-based discovery of orally efficient inhibitors via unique interactions with H-pocket of PDE8 for the treatment of vascular dementia","volume":"12","author":"Wu","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.06.021_bib53","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.apsb.2022.09.023","article-title":"Discovery of novel phosphodiesterase-1 inhibitors for curing vascular dementia: suppression of neuroinflammation by blocking NF-\u03baB transcription regulation and activating cAMP\/CREB axis","volume":"13","author":"Zhou","year":"2023","journal-title":"Acta Pharm Sin B"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524002521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524002521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T04:14:41Z","timestamp":1734408881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383524002521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":53,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2211383524002521"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2024.06.021","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of highly potent phosphodiesterase-1 inhibitors by a combined-structure free energy perturbation approach","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2024.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}